Loading
JPXHealthcareMedical - Healthcare Information Services
Latest quote
¥1,698
−¥3.00 · -0.18%
M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.
Latest quote
¥1,693.5
−¥7.50 · -0.44%
Regular session · JST · Market data may be delayed.
M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.
Day range
Current ¥1,693.5
52-week range
Current ¥1,693.5
Regular session · JST · Market data may be delayed.
M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.
Day range
Current ¥1,693.5
52-week range
Current ¥1,693.5
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 351.36B JPY | 284.9B JPY | 238.88B JPY | 230.82B JPY | 208.16B JPY |
| Cost of goods sold | 175.52B JPY | 130.54B JPY | 98.35B JPY | 95.63B JPY | 84.89B JPY |
| Gross profit | 175.84B JPY | 154.36B JPY | 140.53B JPY | 135.19B JPY | 123.27B JPY |
| Selling, general, and administrative | 105.74B JPY | 82.37B JPY | 67.65B JPY | 58.99B JPY | 51.14B JPY |
| Operating expenses | 105.74B JPY | 92.95B JPY | 75B JPY | 64.83B JPY | 56.07B JPY |
| Interest income | 3.74B JPY | 2.53B JPY | 4.85B JPY | 2.4B JPY | 1.1B JPY |
| Interest expense | 1.01B JPY | 717M JPY | 391M JPY | 69M JPY | 52M JPY |
| Depreciation and amortization | 17.23B JPY | 12.21B JPY | 8.88B JPY | 7.43B JPY | 6.27B JPY |
| Operating income | 70.1B JPY | 61.42B JPY | 65.53B JPY | 70.35B JPY | 67.2B JPY |
| Net income | 49.1B JPY | 40.48B JPY | 45.27B JPY | 49.03B JPY | 63.85B JPY |
Company facts updated Sep 11, 2026.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 26, 2018 | 2:1 | — | — |
Stock split | Mar 27, 2014 | 200:1 | — | — |
Stock split | Sep 26, 2012 | 3:1 | — | — |
Stock split | Sep 28, 2011 | 2:1 | — | — |
Stock split | Sep 27, 2005 | 2:1 | — | — |
Stock split | Mar 28, 2005 | 3:1 | — | — |
Effective Sep 26, 2018
2:1
Effective Mar 27, 2014
200:1
Effective Sep 26, 2012
3:1
Effective Sep 28, 2011
2:1
Effective Sep 27, 2005
2:1
Effective Mar 28, 2005
3:1
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core Nikkei 225 ETF1329.T4.36B0.21%2.09T JPY0.05%¥6,600-2.24%
iShares Core TOPIX ETF1475.T1.78B0.06%2.91T JPY0.05%¥412.9-0.63%
iShares JPX-Nikkei 400 ETF1364.T545M0.09%595.24B JPY0.05%¥3,698-0.43%
Vanguard Total International Stock ETFVXUS65.31M0.01%646.2B USD0.05%$86.28-1.29%
Vanguard FTSE Developed Markets ETFVEA43.71M0.01%315B USD0.03%$71.92-1.24%
iShares Core MSCI EAFE ETFIEFA32.59M0.02%193.07B USD0.07%$98.51-0.92%
JPMorgan BetaBuilders Japan ETFBBJP16.4M0.08%19.62B USD0.19%$77.79-0.59%
iShares MSCI EAFE Small-Cap ETFSCZ14.94M0.11%12.89B USD0.40%$85.35-0.84%iShares Core Nikkei 225 ETF1329.TiShares Core TOPIX ETF1475.TiShares JPX-Nikkei 400 ETF1364.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFAJPMorgan BetaBuilders Japan ETFBBJPiShares MSCI EAFE Small-Cap ETFSCZAI-generated and delayed market data for informational and educational purposes only. Not investment advice.